Comparative effectiveness of single-stage versus two-stage revision for hip prosthetic joint infection: emulation of the INFORM target trial using electronic health record data - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Effectiveness Comparison of Single-Stage and Two-Stage Revision Strategies for Hip Prosthetic Joint Infections: Insights from an INFORM Target Trial Emulation Utilizing Electronic Health Records

  • By

  • Changqing Zhang

  • Yusheng Li

  • Chi Su

  • Yun Shen

  • Shengdi Lu

  • September 6, 2026

Share

  • 1

    Prosthetic joint infection (PJI) occurs in 1% to 2% of total hip arthroplasties and is associated with significant morbidity and economic burden.

  • 2

    The INFORM trial, published in 2022, was the first randomized controlled trial comparing single-stage and two-stage revision strategies for hip PJI.

  • 3

    At 3 months, single-stage revision showed superior function and fewer intraoperative adverse events compared to two-stage revision.

  • 4

    The study emulated the INFORM trial using electronic health records from three Chinese hospitals to assess the effectiveness of revision strategies.

  • 5

    Differences in patient demographics and microbiological characteristics may affect the applicability of INFORM trial results to Chinese hospitals.

Original Source(s)

Related Content